Search results
Results from the WOW.Com Content Network
E. W. Kemble's "Death's Laboratory" on the cover of Collier's (June 3, 1905). A patent medicine, also known as a proprietary medicine or a nostrum (from the Latin nostrum remedium, or "our remedy") is a commercial product advertised to consumers as an over-the-counter medicine, generally for a variety of ailments, without regard to its actual effectiveness or the potential for harmful side ...
Under Section 287(c) of the Patent Act, however, a claim of patent infringement cannot be maintained against a medical practitioner for performing a medical activity, or against a related health care entity with respect to such medical activity, unless the medical practitioner is working in a clinical diagnostic laboratory. [44]
E. W. Kemble's "Death's Laboratory" on the cover of the 3 June 1905 edition of Collier's. A patent medicine (sometimes called a proprietary medicine) is a non-prescription medicine or medicinal preparation that is typically protected and advertised by a trademark and trade name, and claimed to be effective against minor disorders and symptoms, [1] [2] [3] as opposed to a prescription drug that ...
An early example of a food patent is the patent granted to RiceTec for basmati rice in 1997. [6] In 1999, a patent was filed for a peanut butter and jelly sandwich that was without crust. [7] Agriculture giant Monsanto filed for a patent on certain pig genes in 2004. [8]
Under United States law, a patent is a right granted to the inventor of a (1) process, machine, article of manufacture, or composition of matter, (2) that is new, useful, and non-obvious.
WASHINGTON (Reuters) -The U.S. Federal Trade Commission (FTC) on Tuesday said it sent letters to medical device companies and drugmakers, including AbbVie, AstraZeneca and Teva, disputing the ...
Radithor was a patent medicine that is a well-known example of radioactive quackery. It consisted of triple-distilled water containing at a minimum 1 microcurie (37 kBq ) each of the radium-226 and 228 isotopes.
Bristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on blockbuster blood cancer drug Pomalyst for years after it ...